Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, offering promising breakthroughs across various clinical and industrial apps. With its structural similarity to The natural way derived human serum albumin, OsrHSA offers a safer, additional trustworthy alternate for therapeutic use